Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. (ALLR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ALLR · as of Jun 8, 2026
Key Statistics
Explore Allarity Therapeutics, Inc. Data
allr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
allr competitorsALLR
BCTX
CASI
CING
CLSD
CRISStock Performance
Full HistoryAbout Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific c…
what is allarity therapeutics, inc. · allr stock overview · allarity therapeutics, inc. company profile · who is allarity therapeutics, inc. ceo · allr NASDAQ · allarity therapeutics, inc. headquarters · allarity therapeutics, inc. business segments
About Stock Overview & Key Data
Allarity Therapeutics, Inc. (ALLR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 21, 2021. As of the latest trading session, ALLR stock price is $1.58, with a market capitalization of $25.1M. The stock has returned +79.28% over the past 12 months and +46.30% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Allarity Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Allarity Therapeutics, Inc. reported revenue of $320000.00 and net income of -$11.2M. For detailed data — including Allarity Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Allarity Therapeutics, Inc. (ALLR) stock price is $1.58. The stock is traded on NASDAQ under the ticker symbol ALLR. The 52-week range is $0.77 – $2.35.